PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: PathXL

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PathXL Adds Breast Algorithm to its Tumor Analysis Software - PathXL announces the launch of a new algorithm for their latest solution in Image Analysis, TissueMark -
PathXL Adds Breast Algorithm to its Tumor Analysis Software


NewswireToday - /newswire/ - Belfast, United Kingdom, 2014/06/27 - PathXL announces the launch of a new algorithm for their latest solution in Image Analysis, TissueMark - NYSE: PHG, AEX: PHIA

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


In addition to colorectal and non-small cell lung cancer it is now possible for TissueMark to support tissue analysis on breast tissue slides.

Awarded Frost & Sullivan European New Product Innovation for Automated Image Analysis for Digital Pathology, TissueMark® is an easy to use software tool which offers rapid assistance for the pathologist in the analysis of H&E stained digital slides. It provides automated calculations for the percentage tumor burden within a tissue section, highlights the areas of higher tumor concentration through display of a high resolution heatmap, and then clearly marks up the boundaries of the tumor tissue for subsequent dissection.

TissueMark® supports pathologists by estimating tumor content with accurate automated analysis, optimizes slide handling and laboratory workflow while also accelerating the entire macrodissection process. The software allows the pathologists to review results and annotations and provide corrections where they see necessary, which means they remain in control of the final decision.

Officially launched last November at the Association of Molecular Pathology annual conference, TissueMark® has been extremely well received and continues to evolve rapidly. PathXL has recently incorporated several new features to this application, including increased resolution versions of all algorithms and their most detailed heatmap to date, which together enable the detection of even smaller regions of tumor. TissueMark® can now accurately and rapidly handle full tissue sections and tissue biopsies.

“The new PathXL breast cancer algorithm is a very important addition to our TissueMark tumour analysis portfolio, and has been developed as a result of extensive dialogue with our international panel of clients and advisors. We are proud and very excited at the pace with which our strategy is coming to fruition, and are confident that similar success will follow with further new algorithms, due to be released in the coming months.” says PathXL CEO, Des Speed.

Initially released for non-small cell lung cancer and colorectal cancer, TissueMark® now has a new high resolution algorithm for breast cancer tissue. This is the most common cancer in women worldwide, and identifying new breast cancer sub-types, by understanding their molecular abnormalities and targeting these with new drugs, is the basis of modern research. This work is being carried out in pharmaceutical organizations, diagnostic companies, and university research centers across the world.

Most research studies, however, start with the tissue sample and the pathologist, where sufficient tumor cells are necessary for analysis. But significant differences on tumor cell estimations were found to be made across both pathologists and laboratories in the estimate of tumor content in tissue sections. The reason for this lies squarely with the subjective nature of human analysis, as this work is currently done by eye, and may ultimately lead to an increase in false negative results in the subsequent molecular analysis and thus affect biomarker discovery and clinical trials.

As TissueMark® analyses the tissue samples using a powerful and reliable algorithm, this removes subjectivity from the test, making it easier to establish a solid pattern of consistent and accurate results for tumor burden and tumor boundary annotation across pathologists and laboratories.

PathXL’s software has been shown to consistently and accurately annotate tissue samples for macrodissection, and has been validated by experienced pathologists for each of the tumor types it can detect. TissueMark® estimations of percentage tumor cells against actual cell counts have shown a very strong correlation, and there is complete concordance between the results of molecular assays following TissueMark® annotation, as compared to conventional manual annotation.

The release of the breast cancer algorithm brings TissueMark® to a total number of three supported tissue types breast, lung and colorectal and PathXL is making significant progress on new algorithms such as prostate and melanoma, due to be released later this year.

About PathXL
PathXL (, twice recipient of the Deloitte Technology Fast 50 Award, is a global pioneer in the use of web-based solutions for digital pathology, and provides innovative software for use in drug discovery research, clinical sectors, biomarker analysis and education. TissueMark®, its latest product for Image Analysis, is fast-tracking tumor annotation and streamlining macrodissection for molecular analysis and biomarker discovery.

TissueMark® is for Research Use Only. Not for use in Diagnostic Procedures

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: PathXL


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!

PathXL Adds Breast Algorithm to its Tumor Analysis Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

PathXL | TissueMark®
Publisher Contact: Press Office - 
+44(0)28 9073 8712 contact[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PathXL securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From PathXL / Company Profile

Read Research Most Recent Related Newswires:

DSM Launches ForTii® Ace Next Generation High Performance Polyamides
DSM Launches New Cultures to Reduce Cheese Ripening Time
DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category
DSM to Highlight its Health and Indulgence Solutions for Baked Goods At IBIE
DSM Welcomes EU Novel Foods Approval for Heart Health Antioxidant
DSM Dyneema Successfully Defends Key Patent Against Competitor Challenge
DSM Expands its Automotive Electronics Portfolio with High-flow Akulon PA66
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
BD Announces New Software Release for Pyxis Enterprise Solution
DSM Opens its Asia Pacific Personal Care Technical & Application Center in Shanghai
IBM Research Opens in South Africa - Cognitive Computing and the IoT help Track Diseases and Forecast Air Quality
BD Cited as Infusion Pump EMR Integration Leader in Klas Report
DSM to Launch A New Uralac® EasyCure Low Bake/fast Cure Matte Architectural HAA Powder Coating Resins System
IBM Researchers Use Grocery Scanner Data to Speed Investigations During Early Foodborne Illness Outbreaks
DSM Informs Market of Final Pricing of Patheon N.V. IPO

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.

  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (